Prognostic endpoints’ definition

KM Keita Miura
OY Ou Yamaguchi
KM Keita Mori
AN Atsushi Nakamura
MT Motohiro Tamiya
TO Tomohiro Oba
NY Noriko Yanagitani
HM Hideaki Mizutani
TN Takashi Ninomiya
TK Tomosue Kajiwara
KI Kentaro Ito
AM Akihiko Miyanaga
DA Daisuke Arai
HK Hiroaki Kodama
KK Kunihiko Kobayashi
KK Kyoichi Kaira
request Request a Protocol
ask Ask a question
Favorite

The periods considered for overall survival (OS) versus progression free survival (PFS) events were as follows: initiation of RD till the date of mortality due to any cause versus initiation of RD till the dates of exacerbation or mortality due to any cause, or initiation of third-line treatment.

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A